Synthetic fiber treatment agent and synthetic fiber

IN605316BActive Publication Date: 2026-10-08TAKEMOTO OIL & FAT CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
IN202327057520
Authority / Receiving Office
IN · IN
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-04-05
Filing Date
2023-08-28
Publication Date
2026-10-08
Estimated Expiration
2042-03-28

AI Technical Summary

Technical Problem

Conventional synthetic fiber treatment agents face challenges with low preservation stability, particularly in maintaining heat resistance and stability over time, as they tend to precipitate foreign matter during storage.

Method used

A synthetic fiber treatment agent comprising a smoothing agent, a nonionic surfactant, an ionic surfactant including a specific phosphoric acid ester compound, and an alcohol compound, where the phosphoric acid ester compound includes specific phosphoric acid esters and the alcohol compound is selected from monohydric and diols, improving both heat resistance and stability during preservation.

Benefits of technology

The treatment agent effectively enhances the preservation stability and heat resistance, reducing the formation of precipitates and tar, while minimizing tension fluctuations during yarn production.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention addresses the problem of providing: a synthetic fiber treatment agent configured so that the heat resistance and the storage stability of the treatment agent can be improved; and a synthetic fiber to which the treatment agent has been applied. This synthetic fiber treatment agent contains: a smoothing agent (A); a non-ionic surfactant (B); an ionic surfactant (C) containing a phosphoester compound (C1); and an alcohol compound (D). The phosphoester compound (C1) includes at least one selected from phosphoesters P1, P2, P3, and P4 which are respectively represented by prescribed chemical formulas. When the total of p nuclear NMR integration ratios attributed to phosphoesters P1 through P4 is 100%, the p nuclear NMR integration ratio attributed to phosphoester P1 is 7% or less.
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention relates to a synthetic fiber treatment agent that contains a specific phosphoric acid ester compound and a synthetic fiber to which the synthetic fiber treatment agent is adhered.BACKGROUND ART

[0002] Generally, a synthetic fiber treatment agent may adhere to the surface of a synthetic fiber from standpoints of reducing friction and reducing yarn breakage or other damage of the fiber in a spinning and drawing process of the synthetic fiber.

[0003] Patent Documents 1 and 2 disclose known synthetic fiber treatment agents. Patent Document 1 discloses a synthetic fiber treatment agent that contains a smoothing agent, a specific phosphoric acid ester or an organic amine salt thereof, and a nonionic surfactant. Patent Document 2 discloses a synthetic fiber treatment agent that contains a specific organic sulfonic acid compound, an organic phosphoric acid ester compound, and a nonionic surfactant.CITATION LISTPATENT LITERATURE

[0004] Patent Document 1: Japanese Laid-Open Patent Publication No. 2015-038260Patent Document 2: Japanese Laid-Open Patent Publication No. 2016-084566SUMMARY OF INVENTIONTECHNICAL PROBLEM

[0005] However, some conventional synthetic fiber treatment agents have a problem of low preservation stability, for example, foreign matter precipitates with elapse of time during preservation of the treatment agents. In particular, it is difficult to realize both improvement of heat resistance and improvement of stability during preservation of the treatment agents at the same time.SOLUTION TO PROBLEM

[0006] As a result of performing research toward solving the above problem, the inventors of the present application found that a synthetic fiber treatment agent is suitable that contains a smoothing agent, a nonionic surfactant, an alcohol compound, and a specific phosphoric acid ester compound.

[0007] To solve the above problem and in accordance with one aspect of the present invention, a synthetic fiber treatment agent is characterized by containing a smoothing agent (A), a nonionic surfactant (B), an ionic surfactant (C) including a phosphoric acid ester compound (C1) described below, and an alcohol compound (D).

[0008] The phosphoric acid ester compound (C1) includes at least one selected from among a phosphoric acid ester P1 represented by Chemical Formula (1) shown below, a phosphoric acid ester P2 represented by Chemical Formula (2) shown below, a phosphoric acid ester P3 represented by Chemical Formula (3) shown below, and a phosphoric acid ester P4 represented by Chemical Formula (4) shown below. Assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 7%.

[0009] [Chemical Formula 1]

[0010] In Chemical Formula (1),R1 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms,M1 and M2 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and m is an integer of 2 or 3.

[0011] [Chemical Formula 2]

[0012] In Chemical Formula (2),R2 and R3 are each an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms,M3 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and n is an integer of 2 or 3.

[0013] [Chemical Formula 3]

[0014] In Chemical Formula (3),R4 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, andM4 and M5 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium.

[0015] [Chemical Formula 4]

[0016] In Chemical Formula (4),R5 and R6 are each an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, andM6 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium.

[0017] In the synthetic fiber treatment agent, the phosphoric acid ester compound (C1) may include the phosphoric acid ester P2 and assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 may be not less than 5% and not more than 50%.

[0018] In the synthetic fiber treatment agent, the phosphoric acid ester compound (C1) may include the phosphoric acid ester P2 and assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 may be not more than 5%, and the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 may be not less than 10% and not more than 45%.

[0019] In the synthetic fiber treatment agent, the alcohol compound (D) may include at least one selected from among monohydric alcohols and diols.In the synthetic fiber treatment agent, the alcohol compound (D) may include amonohydric alcohol and the content of the monohydric alcohol in the synthetic fiber treatment agent may be not less than 0.0001% by mass and not more than 3% by mass.

[0020] In the synthetic fiber treatment agent, the alcohol compound (D) may include a diol and the content of the diol in the synthetic fiber treatment agent may be not less than 0.001% by mass and not more than 5% by mass.

[0021] In the synthetic fiber treatment agent, the smoothing agent (A) may include at least one selected from among a complete ester compound (A1) described below, a sulfur-containing ester compound (A2), and a partial ester compound (A3) described below.

[0022] The complete ester compound (A1) is at least one selected from among complete ester compounds of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms and complete ester compounds of a monohydric alcohol with not less than 8 and not more than 24 carbon atoms and a polyvalent fatty acid with not less than 3 and not more than 10 carbon atoms.

[0023] The partial ester compound (A3) is a partial ester compound of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms.In the synthetic fiber treatment agent, the smoothing agent (A) may include the complete ester compound (A1) and the content of the complete ester compound (A1) in the synthetic fiber treatment agent may be not less than 30% by mass and not more than 70% by mass.

[0024] In the synthetic fiber treatment agent, the smoothing agent (A) may include the sulfur-containing ester compound (A2).In the synthetic fiber treatment agent, the mass ratio of the contents of the completeester compound (A1) and the sulfur-containing ester compound (A2) may be such that complete ester compound (A1) / sulfur-containing ester compound (A2) is not less than 1 / 1 and not more than 100 / 1.

[0025] In the synthetic fiber treatment agent, the smoothing agent (A) may include the partial ester compound (A3).In the synthetic fiber treatment agent, the mass ratio of the contents of the complete ester compound (A1) and the partial ester compound (A3) may be such that complete ester compound (A1) / partial ester compound (A3) is not less than 1 / 1 and not more than 10000 / 1.

[0026] The synthetic fiber treatment agent may have a phosphoric acid ion concentration of not more than 200 ppm as measured by an ion chromatography method.To solve the above problem and in accordance with another aspect of the present invention, a synthetic fiber is characterized by having the synthetic fiber treatment agent adhered thereto.ADVANTAGEOUS EFFECTS OF INVENTION

[0027] The present invention succeeds in improving both the heat resistance and the stability during preservation of a synthetic fiber treatment agent at the same time.DESCRIPTION OF EMBODIMENTS

[0028] <First Embodiment>A first embodiment that embodies a synthetic fiber treatment agent of the present invention (referred to hereinafter as treatment agent) will now be described. The treatment agent of the present embodiment contains a smoothing agent (A), a nonionic surfactant (B), an ionic surfactant (C) that includes a phosphoric acid ester compound (C1), and an alcohol compound (D). Unlike an acrylic fiber treatment agent for production of carbon fiber, such as that disclosed, for example, in International Publication No. WO 2013 / 129115, the treatment agent is preferably used for treatment of a synthetic fiber other than an acrylic fiber for production of carbon fiber.

[0029] (Smoothing agent (A))Examples of the smoothing agent (A) include a silicone oil, a mineral oil, a polyolefin, and an ester oil. The smoothing agent (A) imparts smoothness to the synthetic fiber.

[0030] The silicone oil is not particularly limited, and specific examples thereof include dimethyl silicones, phenyl-modified silicones, amino-modified silicones, amide-modified silicones, polyether-modified silicones, aminopolyether-modified silicones, alkyl-modified silicones, alkylaralkyl-modified silicones, alkylpolyether-modified silicones, ester-modified silicones, epoxy-modified silicones, carbninol-modified silicones, mercapto-modified silicones, and polyoxyalkylene-modified silicones. As these silicone oils, commercial products can be used as appropriate.

[0031] Examples of the mineral oil include an aromatic hydrocarbon, a paraffin hydrocarbon, and a naphthene hydrocarbon. More specific examples thereof include spindle oil and liquid paraffin. As these mineral oils, commercial products can be used as appropriate. A mineral oil having a kinematic viscosity at 40°C of not less than 5 mm2 / s is used.

[0032] As the polyolefin, a poly-α-olefin used as a smoothing ingredient is applied. Specific examples of the polyolefin include poly-α-olefins that are obtained by polymerizing 1-butene, 1-hexene, 1-decene, or the like. As the poly-α-olefin, a commercial product can be used as appropriate.

[0033] The ester oil is not particularly limited, and examples thereof include an ester oil produced from a fatty acid and an alcohol. Specific examples of the ester oil include an ester oil produced from a fatty acid having an odd number or an even number of hydrocarbon groups and an alcohol that are to be described below.

[0034] The fatty acid that is a raw material of the ester oil is not particularly limited in regard to its number of carbon atoms, whether or not it is branched, and valence, and it may, for example, be a higher fatty acid, a fatty acid having a cyclo ring, or a fatty acid having an aromatic ring. The alcohol that is a raw material of the ester oil is not particularly limited in regard to its number of carbon atoms, whether or not it is branched, and valence, and it may, for example, be a higher alcohol, an alcohol having a cyclo ring, or an alcohol having an aromatic ring.

[0035] The ester oil preferably includes at least one selected from among a complete ester compound (A1), a sulfur-containing ester compound (A2), and a partial ester compound (A3). The ester oil more preferably includes the sulfur-containing ester compound (A2). By such arrangement, tension fluctuation can be suppressed by improvement of heat resistance. The ester oil more preferably includes the partial ester compound (A3). By such arrangement, tar can be suppressed by improvement of compatibility.

[0036] The complete ester compound (A1) is at least one selected from among complete ester compounds of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms and complete ester compounds of a monohydric alcohol with not less than 8 and not more than 24 carbon atoms and a polyvalent fatty acid with not less than 3 and not more than 10 carbon atoms. However, a dibasic acid that contains a sulfur atom in the molecule, such as thiodipropionic acid or dithiodipropionic acid, shall not be included in the polyvalent fatty acid in the ester compound (A1).

[0037] The partial ester compound (A3) is a partial ester compound of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms.Examples of the polyhydric alcohol having a chain structure include a polyhydric alcohol not having a cyclic structure. The chain structure may be that of a straight chain form or may be that having a branched chain structure. Specific examples of the polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms include glycerin, diglycerin, pentaerythritol, sorbitol, trimethylolethane, trimethylolpropane, butanetriol, pentanetriol, and hexanetriol.

[0038] As the monovalent fatty acid with not less than 8 and not more than 24 carbon atoms, a known monovalent fatty acid can be used as appropriate and it may be a saturated fatty acid or may be an unsaturated fatty acid. Alternatively, it may be that of a straight chain form or may be that having a branched chain structure. Specific examples of the saturated fatty acid include octanoic acid (caprylic acid), nonanoic acid, decanoic acid (capric acid), dodecanoic acid (lauric acid), tetradecanoic acid (myristic acid), hexadecanoic acid (palmitic acid), octadecanoic acid (stearic acid), eicosanoic acid (arachidic acid), docosanoic acid (behenic acid), and tetracosanoic acid. Specific examples of the unsaturated fatty acid include myristoleic acid, palmitoleic acid, oleic acid, vaccenic acid, eicosenoic acid, linoleic acid, α-linolenic acid, γ-linolenic acid, and arachidonic acid.

[0039] As the monohydric alcohol with not less than 8 and not more than 24 carbon atoms, a known monohydric alcohol can be used as appropriate and it may be a saturated aliphatic monohydric alcohol or may be an unsaturated aliphatic monohydric alcohol. Alternatively, it may be that of a straight chain form or may be that having a branched chain structure.Specific examples of the monohydric alcohol with not less than 8 and not more than 24carbon atoms include straight-chain alkyl alcohols, such as octanol, nonanol, decanol, undecanol, dodecanol, tridecanol, tetradecanol, pentadecanol, hexadecanol, heptadecanol, octadecanol, nonadecanol, eicosanol, heneicosanol, docosanol, tricosanol, and tetracosanol, branched alkyl alcohols, such as isooctanol, isononanol, isodecanol, isododecanol, isotridecanol, isotetradecanol, isotriacontanol, isohexadecanol, isoheptadecanol, isooctadecanol, isononadecanol, isoeicosanol, isoheneicosanol, isodocosanol, isotricosanol, and isotetracosanol, and straight-chain alkenyl alcohols, such as tetradecenol, hexadecenol, heptadecenol, octadecenol, and nonadecenol.

[0040] As the polyvalent fatty acid with not less than 3 and not more than 10 carbon atoms, a known polyvalent fatty acid can be used as appropriate and it may be a saturated fatty acid, may be an unsaturated fatty acid, or may be an aromatic carboxylic acid. Specific examples of the polyvalent fatty acid with not less than 3 and not more than 10 carbon atoms include aliphatic carboxylic acids, such as malonic acid, succinic acid, glutaric acid, adipic acid, fumaric acid, maleic acid, and aconitic acid, and aromatic carboxylic acids, such as terephthalic acid, isophthalic acid, and trimellitic acid.

[0041] Specific examples of the complete ester compound (A1) include trimethylolpropane trioleate, diisostearyl adipate, and natural oils and fats, such as coconut oil, rapeseed oil, sunflower oil, soybean oil, castor oil, sesame oil, palm oil, fish oil, and beef tallow.

[0042] Specific examples of the sulfur-containing ester compound (A2) include dioctyl thiodipropionate, diisolauryl thiodipropionate, dilauryl thiodipropionate, diisocetyl thiodipropionate, diisostearyl thiodipropionate, dioleyl thiodipropionate, octyl thiodipropionate, isolauryl thiodipropionate, lauryl thiodipropionate, isocetyl thiodipropionate, isostearyl thiodipropionate, oleyl thiodipropionate, octyl mercaptopropionate, stearyl mercaptopropionate, trimethylolpropanetris(mercaptopropionate), and dioctyl dithiodipropionate.

[0043] Specific examples of the partial ester compound (A3) include trimethylolpropane monooleate, glycerin monooleate, diglycerin dilaurate, trimethylolpropane dioleate, and glycerin dioleate.

[0044] The lower limit of the content of the complete ester compound (A1) in the treatment agent is selected as appropriate and is preferably not less than 30% by mass and more preferably not less than 35% by mass. The upper limit of the content thereof is selected as appropriate and is preferably not more than 70% by mass and more preferably not more than 65% by mass. Any combination of the abovementioned upper and lower limits may be used. By specifying to be in such range, the effects of the present invention can be further improved.

[0045] In the treatment agent, the mass ratio of the contents of the complete ester compound (A1) and the sulfur-containing ester compound (A2) is preferably such that complete ester compound (A1) / sulfur-containing ester compound (A2) is not less than 1 / 1 and not more than 100 / 1. By specifying to be in such range, the tension fluctuation can be suppressed.

[0046] In the treatment agent, the mass ratio of the contents of the complete ester compound (A1) and the partial ester compound (A3) is preferably such that complete ester compound (A1) / partial ester compound (A3) is not less than 1 / 1 and not more than 10000 / 1. By specifying to be in such range, accumulation of tar can be suppressed.

[0047] An ester oil other than the ester oils mentioned above may be used. Specific examples of such an ester oil include (1) ester compounds of an aliphatic monoalcohol and an aliphatic monocarboxylic acid, such as octyl palmitate, oleyl laurate, oleyl oleate, isotridecyl stearate, and isotetracosyl oleate, and (2) ester compounds of an aromatic alcohol and analiphatic carboxylic acid, such as benzyl oleate, benzyl laurate, and bisphenol A dilaurate.

[0048] With these smoothing agents (A), one type of smoothing agent may be used alone or two or more types of smoothing agents may be used in combination as appropriate.(Nonionic surfactant (B))Examples of the nonionic surfactant (B) include an adduct of an alkylene oxide with an alcohol or a carboxylic acid, an ether ester compound in which an alkylene oxide is added to an ester compound of a carboxylic acid and a polyhydric alcohol, an adduct of an alkylene oxide with an amine compound such as an alkylamine, and a partial ester compound of a carboxylic acid and a polyhydric alcohol having a cyclic structure with not less than 3 and not more than 6 carbon atoms. With these nonionic surfactants (B), one type of nonionic surfactant may be used alone or two or more types of nonionic surfactants may be used in combination as appropriate.

[0049] Specific examples of an alcohol used as a raw material of the nonionic surfactant (B) include (1) straight-chain alkyl alcohols, such as methanol, ethanol, propanol, butanol, pentanol, hexanol, octanol, nonanol, decanol, undecanol, dodecanol, tridecanol, tetradecanol, pentadecanol, hexadecanol, heptadecanol, octadecanol, nonadecanol, eicosanol, heneicosanol, docosanol, tricosanol, tetracosanol, pentacosanol, hexacosanol, heptacosanol, octacosanol, nonacosanol, and triacontanol, (2) branched alkyl alcohols, such as isopropanol, isobutanol, isohexanol, 2-ethylhexanol, isononanol, isodecanol, isododecanol, isotridecanol, isotetradecanol, isotriacontanol, isohexadecanol, isoheptadecanol, isooctadecanol, isononadecanol, isoeicosanol, isoheneicosanol, isodocosanol, isotricosanol, isotetracosanol, isopentacosanol, isohexacosanol, isoheptacosanol, isooctacosanol, isononacosanol, and isopentadecanol, (3) straight-chain alkenyl alcohols, such as tetradecenol, hexadecenol, heptadecenol, octadecenol, and nonadecenol, (4) branched alkenyl alcohols, such asisohexadecenol and isooctadecenol, (5) cyclic alkyl alcohols, such as cyclopentanol and cyclohexanol, and (6) aromatic alcohols, such as phenol, nonylphenol, benzyl alcohol, monostyrenated phenol, distyrenated phenol, and tristyrenated phenol.

[0050] Specific examples of a carboxylic acid used as a raw material of the nonionic surfactant (B) include (1) straight-chain alkyl carboxylic acids, such as octylic acid, nonanoic acid, decanoic acid, undecanoic acid, dodecanoic acid, tridecanoic acid, tetradecanoic acid, pentadecanoic acid, hexadecanoic acid, heptadecanoic acid, octadecanoic acid, nonadecanoic acid, eicosanoic acid, heneicosanoic acid, and docosanoic acid, (2) branched alkyl carboxylic acids, such as 2-ethylhexanoic acid, isododecanoic acid, isotridecanoic acid, isotetradecanoic acid, isohexadecanoic acid, and isooctadecanoic acid, (3) straight-chain alkenyl carboxylic acids, such as octadecenoic acid, octadecadienoic acid, and octadecatrienoic acid, and (4) aromatic carboxylic acid, such as benzoic acid.

[0051] Specific examples of an alkylene oxide used as a raw material of the nonionic surfactant (B) include ethylene oxide and propylene oxide. The number of moles of alkylene oxide added is set as appropriate and is preferably not less than 0.1 mole and not more than 60 moles, more preferably not less than 1 mole and not more than 40 moles, and even more preferably not less than 2 moles and not more than 30 moles. Any combination of the abovementioned upper and lower limits may be used. The number of moles of alkylene oxide added represents the number of moles of the alkylene oxide with respect to 1 mole of the alcohol or the carboxylic acid in the charged raw materials. If a plurality of types of alkylene oxides are used, these may be arranged as a block adduct or a random adduct.

[0052] Specific examples of a polyhydric alcohol used as a raw material of the nonionic surfactant (B) include ethylene glycol, propylene glycol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 2-methyl-1,2-propanediol, 1,5-pentanediol, 1,6-hexanediol, 2,5-hexanediol, 2-methyl-2,4-pentanediol, 2,3-dimethyl-2,3-butanediol, glycerin, 2-methyl-2-hydroxymethyl-1,3-propanediol, trimethylolpropane, sorbitan, pentaerythritol, and sorbitol.

[0053] Specific examples of an alkylamine used as a raw material of the nonionic surfactant (B) include methylamine, ethylamine, butylamine, octylamine, laurylamine, octadecylamine, octadecenylamine, and coconut amine.

[0054] Specific examples of the nonionic surfactant (B) include an adduct of 10 moles of ethylene oxide (referred to hereinafter as EO) with 1 mole of oleyl alcohol, an adduct of 10 moles of EO with 1 mole of isotridecanol, a random adduct of 10 moles of EO and 10 moles of propylene oxide (referred to hereinafter as PO) with 1 mole of isotridecanol, an adduct of 10 moles of EO with 1 mole of hydrogenated castor oil, a compound obtained by adding 20 moles of EO to 1 mole of hydrogenated castor oil and then esterifying with 3 moles of oleic acid, a compound (average molecular weight: 5000) obtained by adding 25 moles of EO to 1 mole of hydrogenated castor oil and then crosslinking with adipic acid and terminal esterifying with stearic acid, sorbitan monooleate, sorbitan trioleate, a diester of polyethylene glycol (average molecular weight: 600) and oleic acid, a diester of polyethylene glycol (average molecular weight: 400) and lauric acid, a monoester of polyethylene glycol (average molecular weight: 600) and oleic acid, an adduct of 3 moles of EO with 1 mole of laurylamine, and an adduct of 10 moles of EO with 1 mole of laurylamine.

[0055] The content of the nonionic surfactant (B) in the treatment agent is set as appropriate and is preferably not less than 5% by mass and not more than 70% by mass, more preferably not less than 10% by mass and not more than 65% by mass, and even more preferably not less than 20% by mass and not more than 60% by mass. Any combination of the abovementioned upper and lower limits may be used. By specifying to be in such range, the effects of the present invention can be further improved.

[0056] (Phosphoric acid ester compound (C1))The phosphoric acid ester compound (C1) includes at least one selected from among a phosphoric acid ester P1 represented by Chemical Formula (1) shown below, a phosphoric acid ester P2 represented by Chemical Formula (2) shown below, a phosphoric acid ester P3 represented by Chemical Formula (3) shown below, and a phosphoric acid ester P4 represented by Chemical Formula (4) shown below.

[0057]

[0058] In Chemical Formula (1),R1 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms,M1 and M2 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and m is an integer of 2 or 3.

[0059] With these phosphoric acid esters P1, one type of phosphoric acid ester P1 may be contained alone or two or more types of phosphoric acid esters P1 may be contained.The alkyl group that constitutes R1 may be a straight-chain alkyl group or an alkyl group having a branched chain structure. The alkenyl group that constitutes R1 may be a straight-chain alkenyl group or an alkenyl group having a branched chain structure.

[0060] Specific examples of the straight-chain alkyl group that constitutes R1 include an octyl group, a nonyl group, a decyl group, a undecyl group, a dodecyl group, a tridecyl group, a tetradecyl group, a pentadecyl group, a hexadecyl group, a heptadecyl group, an octadecyl group, an icosyl group, a docosyl group, a tricosyl group, and a tetracosyl group.

[0061] Specific examples of the alkyl group having a branched chain structure that constitutes R1 include an isooctyl group, an isononyl group, an isodecyl group, an isoundecyl group, an isododecyl group, an isotridecyl group, an isotetradecyl group, an isopentadecyl group, an isohexadecyl group, an isoheptadecyl group, an isooctadecyl group, an isoicosyl group, an isodocosyl group, an isotricosyl group, and an isotetracosyl group.

[0062] Specific examples of the straight-chain alkenyl group that constitutes R1 include an octenyl group, a nonenyl group, a decenyl group, a undecenyl group, a dodecenyl group, a tridecenyl group, a tetradecenyl group, a pentadecenyl group, a hexadecenyl group, a heptadecenyl group, an octadecenyl group, an icosenyl group, a docosenyl group, a tricosenyl group, and a tetracosenyl group.

[0063] Specific examples of the alkenyl group having a branched chain structure that constitutes R1 include an isooctenyl group, an isononenyl group, an isodecenyl group, an isoundecenyl group, an isododecenyl group, an isotridecenyl group, an isotetradecenyl group, an isopentadecenyl group, an isohexadecenyl group, an isoheptadecenyl group, an isooctadecenyl group, an isoicosenyl group, an isodocosenyl group, an isotricosenyl group, and an isotetracosenyl group.

[0064] Specific examples of the aliphatic alcohol with not less than 8 and not more than 24 carbon atoms that constitutes the residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms include the specific examples of aliphatic monohydric alcohols described above as raw materials of the ester oil.

[0065] Specific examples of the alkylene oxide include ethylene oxide and propylene oxide. The number of moles of alkylene oxide added represents the number of moles of the alkylene oxide with respect to 1 mole of the aliphatic alcohol in the charged raw materials. If a plurality of types of alkylene oxides are used, these may be arranged as a block adduct or a random adduct.

[0066] Specific examples of the residue that constitutes R1 and is obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms include a residue obtained by removing a hydroxy group from an adduct of 2 moles of EO with 2-ethyl hexanol, from a random adduct of 2 moles of EO and 2 moles of PO with normal octanol, from an adduct of 3 moles of EO with lauryl alcohol, from an adduct of 3 moles of EO with isolauryl alcohol, from a random adduct of 3 moles of EO and 3 moles of PO with isolauryl alcohol, from an adduct of 3 moles of EO with cetyl alcohol, from an adduct of 3 moles of EO with isocetyl alcohol, from an adduct of 4 moles of EO with oleyl alcohol, from an adduct of 4 moles of EO with isostearyl alcohol, from an adduct of 3 moles of EO with oleyl alcohol, from a random adduct of 4 moles of EO and 4 moles of PO with oleyl alcohol, or from an adduct of 5 moles of EO with isotetradecenyl alcohol.

[0067] M1 and M2 each represent a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium. Since an alkali earth metal is divalent, "alkali earth metal (1 / 2)" indicates that 1 / 2 mole is added at M1 or M2 Specific examples of the alkali metal include sodium, potassium, and lithium. Specific examples of the alkali earth metal include magnesium and calcium.

[0068] Specific examples of the organic amine include (1) aliphatic amines, such as methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, N-N-diisopropylethylamine, butylamine, dibutylamine, 2-methylbutylamine, tributylamine, octylamine, laurylamine, and dimethyllaurylamine, (2) aromatic amines or heterocyclic amines, such as aniline, N-methylbenzylamine, pyridine, morpholine, piperazine, and derivatives thereof, (3) alkanolamines, such as monoethanolamine, N-methylethanolamine, diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine, triisopropanolamine, dibutylethanolamine, butyldiethanolamine, octyldiethanolamine, and lauryldiethanolamine, (4) arylamines, such as 3-aminopropene, and (5) polyoxyalkylene alkyl aminoethers, such as polyoxyethylene lauryl aminoether and polyoxyethylene stearyl aminoether.

[0069] Specific examples of the phosphonium include quaternary phosphoniums, such as tetramethylphosphonium, tetraethylphosphonium, tetrabutylphosphonium, tetraoctylphosphonium, dibutyldihexylphosphonium, trihexyltetradecylphosphonium, triethyloctylphosphonium, and triphenylmethylphosphonium.

[0070] The phosphoric acid ester P2 is represented by Chemical Formula (2) shown below.

[0071]

[0072] In Chemical Formula (2),R2 and R3 are each an alkyl group with not less than 8 and not more than 24 carbonatoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms,M3 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and n is an integer of 2 or 3.

[0073] With these phosphoric acid esters P2, one type of phosphoric acid ester P2 may be used alone or two or more types of phosphoric acid esters P2 may be used in combination as appropriate.The alkyl group that constitutes R2 or R3 may be a straight-chain alkyl group or an alkyl group having a branched chain structure. The alkenyl group that constitutes R2 or R3 may be a straight-chain alkenyl group or an alkenyl group having a branched chain structure.

[0074] Specific examples of the alkyl group that constitutes R2 or R3 include those given as examples of the alkyl group that constitutes R1 of Chemical Formula (1). Specific examples of the alkenyl group that constitutes R2 or R3 include those given as examples of the alkenyl group that constitutes R1 of Chemical Formula (1).

[0075] Specific examples of the residue that constitutes R2 or R3 and is obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms include the specific examples described for R1 of Chemical Formula (1).

[0076] Specific examples of M3 include those given as examples of M1 or M2 of Chemical Formula (1).The phosphoric acid ester P3 is represented by Chemical Formula (3) shown below.

[0077]

[0078] In Chemical Formula (3),R4 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, andM4 and M5 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium.

[0079] With these phosphoric acid esters P3, one type of phosphoric acid ester P3 may be used alone or two or more types of phosphoric acid esters P3 may be used in combination as appropriate.The alkyl group that constitutes R4 may be a straight-chain alkyl group or an alkyl group having a branched chain structure. The alkenyl group that constitutes R4 may be a straight-chain alkenyl group or an alkenyl group having a branched chain structure.

[0080] Specific examples of the alkyl group that constitutes R4 include those given as examples of the alkyl group that constitutes R1 of Chemical Formula (1). Specific examples of the alkenyl group that constitutes R4 include those given as examples of the alkenyl group that constitutes R1 of Chemical Formula (1).

[0081] Specific examples of the residue that constitutes R4 and is obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms include the specific examples described for R1 of Chemical Formula (1).

[0082] Specific examples of M4 or M5 include those given as examples of M1 or M2 of Chemical Formula (1).The phosphoric acid ester P4 is represented by Chemical Formula (4) shown below.

[0083]

[0084] In Chemical Formula (4),R5 and R6 are each an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, andM6 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium.

[0085] With these phosphoric acid esters P4, one type of phosphoric acid ester P4 may be used alone or two or more types of phosphoric acid esters P4 may be used in combination as appropriate.The alkyl group that constitutes R5 or R6 may be a straight-chain alkyl group or an alkyl group having a branched chain structure. The alkenyl group that constitutes R5 or R6 may be a straight-chain alkenyl group or an alkenyl group having a branched chain structure.

[0086] Specific examples of the alkyl group that constitutes R5 or R6 include those given as examples of the alkyl group that constitutes R1 of Chemical Formula (1). Specific examples of the alkenyl group that constitutes R5 or R6 include those given as examples of the alkenyl group that constitutes R1 of Chemical Formula (1).

[0087] Specific examples of the residue that constitutes R5 or R6 and is obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms include the specific examples described for R1 of Chemical Formula (1).

[0088] Specific examples of M6 include those given as examples of M1 or M2 of Chemical Formula (1).With the phosphoric acid ester compound (C1), assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 in a P nucleus NMR measurement made upon performing an alkali over-neutralization pretreatment is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 7%.

[0089] The "alkali over-neutralization pretreatment" means a pretreatment of adding an excess amount of alkali to an alkyl phosphoric acid ester compound. The alkali is not particularly limited and specific examples thereof include organic amines and hydroxides of alkali metals or alkali earth metals. It may be the same as or may be different from the alkali used in synthesizing the phosphoric acid ester salt. Specific examples of the organic amines include those given as examples of the organic amines that constitute the phosphoric acid ester salts described above. Specific examples of the hydroxides of alkali metals or alkali earth metals include sodium hydroxide, potassium hydroxide, and magnesium hydroxide.

[0090] By performing the "alkali over-neutralization pretreatment" in making a 3 [P-NMR measurement, peaks attributed to the phosphoric acid esters P1 to P4 can be separated clearly to enable the P nucleus integral ratios attributed to the respective compounds to be calculated by Numerical Formula (1) to Numerical Formula (4) given below. For a 31P-NMR measurement in the Example section below, an alkali over-neutralization pretreatment of adding an alkali of amount by which observed peaks are separated to the phosphoric acid ester compound was performed.

[0091] The P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is represented by Numerical Formula (1) given below. The P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is represented by Numerical Formula (2) given below. The P nucleus NMR integral ratio attributed to the phosphoric acid ester P3 is represented by Numerical Formula (3) given below. The P nucleus NMR integral ratio attributed to the phosphoric acid ester P4 is represented by Numerical Formula (4) given below.

[0092] [Numerical Formula 1]P1_P% = [P1_P / (P1_P + P2_P + P3_P + P4_P)] x 100 ... (1)

[0093] In Numerical Formula (1),P1_P% expresses the P nucleus NMR integral ratio attributed to the phosphoric acidester P1,P1_P expresses a P nucleus NMR integral value attributed to the phosphoric acidester P1,P2_P expresses a P nucleus NMR integral value attributed to the phosphoric acidester P2,P3_P expresses a P nucleus NMR integral value attributed to the phosphoric acid ester P3, andP4_P expresses a P nucleus NMR integral value attributed to the phosphoric acidester P4.

[0094] [Numerical Formula 2]P2_P% = [P2_P / (P1_P + P2_P + P3_P + P4_P)] x 100 ... (2)

[0095] In Numerical Formula (2),P2_P% expresses the P nucleus NMR integral ratio attributed to the phosphoric acidester P2,P1_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P1,P2_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P2,P3_P expresses the P nucleus NMR integral value attributed to the phosphoric acid ester P3, andP4_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P4.

[0096] [Numerical Formula 3]P3_P% = [P3_P / (P1_P + P2_P + P3_P + P4_P)] x 100 ... (3)

[0097] In Numerical Formula (3),P3_P% expresses the P nucleus NMR integral ratio attributed to the phosphoric acidester P3,P1_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P1,P2_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P2,P3_P expresses the P nucleus NMR integral value attributed to the phosphoric acid ester P3, andP4_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P4.

[0098] [Numerical Formula 4]P4_P% = [P4_P / (P1_P + P2_P + P3_P + P4_P)] x 100 ... (4)

[0099] In Numerical Formula (4),P4_P% expresses the P nucleus NMR integral ratio attributed to the phosphoric acidester P4,P1_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P1,P2_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P2,P3_P expresses the P nucleus NMR integral value attributed to the phosphoric acid ester P3, andP4_P expresses the P nucleus NMR integral value attributed to the phosphoric acidester P4.

[0100] When the phosphoric acid ester compound (C1) includes the phosphoric acid ester P2 and assuming that the total of the P nucleus NMR integral ratios attributed to thephosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is preferably not less than 5% and not more than 50%. By specifying to be in such range, the effects of the present invention can be further improved.

[0101] When the phosphoric acid ester compound (C1) includes the phosphoric acid ester P2 and assuming that the total of the P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, it is preferable that the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 5% and that the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is not less than 10% and not more than 45%. By specifying to be in such range, the effects of the present invention can be further improved.

[0102] When the phosphoric acid ester compound (C1) includes the phosphoric acid ester P2 and assuming that the total of the P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, it is more preferable that the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 5% and that the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is not less than 15% and not more than 40%. By specifying to be in such range, the tension fluctuation can be further reduced. Any combination of the abovementioned upper and lower limits may be used.

[0103] The phosphoric acid ester compound (C1) is obtained by making, for example, diphosphorus pentaoxide react with a saturated aliphatic alcohol or unsaturated aliphatic alcohol with not less than 8 and not more than 24 carbon atoms as a raw material alcohol to obtain an alkyl phosphoric acid ester and thereafter neutralizing or over-neutralizing the alkyl phosphoric acid ester with an alkali, such as potassium hydroxide and an amine, as necessary. With this synthesis method, the phosphoric acid ester compound is usually a mixture of the phosphoric acid ester P1 represented by Chemical Formula (1), the phosphoric acid ester P2 represented by Chemical Formula (2), the phosphoric acid ester P3 represented by Chemical Formula (3), and the phosphoric acid ester P4 represented by Chemical Formula (4). In such a mixture, the phosphoric acid ester P1 is particularly susceptible to decomposition during preservation, readily forming inorganic phosphoric acid and salts thereof. In particular, this occurs prominently when water is contained in the treatment agent. The inorganic phosphoric acid and salts thereof precipitate from the treatment agent and decrease the heat resistance of the treatment agent and thus affect yarn production adversely. In order to make the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 not more than 7%, it is preferable to make the reaction proceed while avoiding contact with moisture by a method such as dehydrating the raw materials before the phosphorylation step or using an inert gas atmosphere in the phosphorylation step, and it is especially preferable to avoid the use of moistened diphosphorus pentaoxide. The phosphoric acid ester P1 may be decreased in its content by decomposing it by adding water to the phosphoric acid ester compound (C1) and heating to approximately 100°C. In this process, the inorganic phosphoric acid and salts thereof are formed due to thermolysis of the phosphoric acid ester P1. The inorganic phosphoric acid and salts thereof are preferably eliminated from the treatment agent from a standpoint of improving the heat resistance. For elimination of these, a known purification art, for example, an adsorption treatment can be used. The phosphoric acid ester compound (C1) may be prepared by mixing the phosphoric acid ester P1 represented by Chemical Formula (1), the phosphoric acid ester P2 represented by Chemical Formula (2), the phosphoric acid ester P3 represented by Chemical Formula (3), and the phosphoric acid ester P4 represented by Chemical Formula (4).

[0104] The content of the phosphoric acid ester compound (C1) in the treatment agent is set as appropriate and, in a state where a salt is not formed by a neutralizer, it is preferably not less than 0.1% by mass and not more than 10% by mass and more preferably not less than 0.3% by mass and not more than 5% by mass. Any combination of the abovementioned upper and lower limits may be used. By specifying to be in such range, the effects of the present invention can be further improved. Also, by specifying to be in such range, functions of the treatment agent, such as antistatic property, can be efficiently exhibited.

[0105] (Ionic surfactant (C))The treatment agent may contain an ionic surfactant (C) other than the phosphoric acid ester compound (C1). As the ionic surfactant (C) other than the phosphoric acid ester compound (C1), a known ionic surfactant can be used as appropriate. Examples of the ionic surfactant include an anionic surfactant, a cationic surfactant, and an amphoteric surfactant.

[0106] Specific examples of the anionic surfactant include (1) aliphatic sulfonic acid salts or aromatic sulfonic acid salts, such as lauryl sulfonic acid salts, myristyl sulfonic acid salts, cetyl sulfonic acid salts, oleyl sulfonic acid salts, stearyl sulfonic acid salts, tetradecane sulfonic acid salts, α-olefin sulfonic acids, dodecylbenzene sulfonic acid salts, and secondary alkyl sulfonic acid salts, (2) sulfuric acid ester salts of aliphatic alcohols, such as lauryl sulfuric acid ester salts, oleyl sulfuric acid ester salts, and stearyl sulfuric acid ester salts, (3) sulfuric acid ester salts of adducts of at least one type of alkylene oxide selected from among EO and PO with an aliphatic alcohol, such as polyoxyethylene lauryl ether sulfuric acid ester salts, polyoxyalkylene (polyoxyethylene, polyoxypropylene) lauryl ether sulfuric acid ester salts, and polyoxyethylene oleyl ether sulfuric acid ester salts, (4) sulfuric acid ester salts of fatty acids, such as castor oil fatty acid sulfuric acid ester salts, sesame oil fatty acid sulfuric acid ester salts, tall oil fatty acid sulfuric acid ester salts, soybean oil fatty acid sulfuric acid ester salts, rapeseed oil fatty acid sulfuric acid ester salts, palm oil fatty acid sulfuric acid ester salts, lard fatty acid sulfuric acid ester salts, beef tallow fatty acid sulfuric acid ester salts, and whale oil fatty acid sulfuric acid ester salts, (5) sulfuric acid ester salts of oils and fats, such as sulfuric acid ester salts of castor oil, sulfuric acid ester salts of sesame oil, sulfuric acid ester salts of tall oil, sulfuric acid ester salts of soybean oil, sulfuric acid ester salts of rapeseed oil, sulfuric acid ester salts of palm oil, sulfuric acid ester salts of lard, sulfuric acid ester salts of beef tallow, and sulfuric acid ester salts of whale oil, (6) fatty acid salts, such as lauric acid salts, oleic acid salts, stearic acid salts, and dodecenyl succinic acid salts, and (7) sulfosuccinic acid ester salts of aliphatic alcohols, such as dioctyl sulfosuccinic acid salts. Examples of a counterion of the anionic surfactant include alkali metal salts, such as a potassium salt and a sodium salt, an ammonium salt, and alkanolamine salts, such as triethanolamine.

[0107] Specific examples of the cationic surfactant include lauryltrimethylammonium chloride, cetyltrimethylammonium chloride, stearyltrimethylammonium chloride, behenyltrimethylammonium chloride, and didecyldimethylammonium chloride.

[0108] Specific examples of the amphoteric surfactant include a betaine amphoteric surfactant.With these ionic surfactants (C), one type of ionic surfactant may be used alone or two or more types of ionic surfactants may be used in combination as appropriate.

[0109] (Alcohol compound (D))The alcohol compound (D) exhibits an action of further improving the stability during preservation of the treatment agent. It also exhibits an action of further improving the heat resistance of the treatment agent. Examples of the alcohol compound (D) include amonohydric alcohol and a polyhydric alcohol. The alcohol compound (D) preferably includes one selected from among monohydric alcohols and diols. By such a compound, shedding of treatment agent precipitate onto a heating roller is suppressed and accumulation of tar is suppressed. Examples of the monohydric alcohol include a lower alcohol and a higher alcohol. Examples of the higher alcohol include a aliphatic monohydric alcohol with not less than 8 and not more than 24 carbon atoms.

[0110] As the monohydric alcohol, there is no limitation in particular as to whether or not it has an unsaturated bond and it may be an alcohol having a hydrocarbon group of straight chain form or branched chain form or it may be an alcohol having a cyclo ring. In the case of the alcohol having a hydrocarbon group of branched chain form, a branching position thereof is not particularly limited. It may be a primary, secondary, or tertiary alcohol. Specific example of the monohydric alcohol include methanol, ethanol, propanol, octyl alcohol, nonanol, decanol, undecanol, lauryl alcohol, tridecyl alcohol, myristyl alcohol, pentadecyl alcohol, cetanol, stearyl alcohol, eicosanol, behenyl alcohol, tetracosanol, oleyl alcohol, isopropanol, 2-ethylhexanol, isododecyl alcohol, isotridecyl alcohol, isomyristyl alcohol, isocetanol, isostearyl alcohol, and isotetracosanol.

[0111] Specific examples of the diol include ethylene glycol, propylene glycol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 2-methyl-1,2-propanediol, 1,5-pentanediol, 1,6-hexanediol, 2,5-hexanediol, 2-methyl-2,4-pentanediol, 2,3-dimethyl-2,3-butanediol, diethylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, and copolymers of polyethylene glycol and polypropylene glycol. With these alcohol compounds (D), one type of alcohol compound may be used alone or two or more types of alcohol compounds may be used in combination as appropriate. Among these, a (poly)alkylene oxide is preferable from a standpoint of improving stability.

[0112] The content of the monohydric alcohol in the treatment agent is set as appropriate and is preferably not less than 0.0001% by mass and not more than 3% by mass, more preferably not less than 0.001% by mass and not more than 2.5% by mass, and even more preferably not less than 0.01% by mass and not more than 2% by mass. Any combination of the abovementioned upper and lower limits may be used. By specifying to be in such range, the stability is further improved and the accumulation of tar is further suppressed.

[0113] The content of the diol in the treatment agent is set as appropriate and is preferably not less than 0.001% by mass and not more than 5% by mass and more preferably not less than 0.01% by mass and not more than 4% by mass. Any combination of the abovementioned upper and lower limits may be used. By specifying to be in such range, the stability is further improved and the accumulation of tar is further suppressed.

[0114] (Others)The treatment agent has a phosphoric acid ion concentration of preferably not more than 200 ppm and more preferably not more than 150 ppm as measured by an ion chromatography method. By specifying to be in such range, accumulation of the treatment agent or tar on the heating roller is suppressed.

[0115] <Second Embodiment>Next, a second embodiment that embodies a synthetic fiber according to the present invention will be described. The synthetic fiber of the present embodiment has the treatment agent of the first embodiment adhered thereto. As to the form of the treatment agent in adhering the treatment agent to synthetic fibers, it may be applied as a dilute solution diluted by a diluent solvent, for example, as a low-viscosity mineral oil solution, an organic solvent solution, or an aqueous liquid. The treatment agent of the first embodiment succeeds in improving the preservation stability of the treatment agent diluted in a nonpolar solvent, such as a low-viscosity mineral oil, in particular. The synthetic fiber is obtained through a step of adhering a dilute solution of the treatment agent, such as an aqueous liquid, to the synthetic fiber, for example, in a spinning or drawing process. With the dilute liquid adhered to the synthetic fiber, the diluent solvent may be evaporated by a drawing process or a drying process. Adhesion of the treatment agent to the synthetic fiber is not limited in particular in its timing as long as it is performed in the spinning process. In a drawing process or a heat treatment process, the effects of the invention can be expected more by use in production equipment having a step of passing through rollers of 150°C or higher or in such a step.

[0116] The synthetic fiber to which the treatment agent of the present embodiment is applied is not particularly limited, and specific examples thereof include (1) a polyester fiber, such as polyethylene terephthalate (PET), polytrimethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, polylactic acid, or a composite fiber containing these polyester resins, (2) a polyamide fiber, such as nylon 6 or nylon 66, (3) a polyacrylic fiber, such as polyacrylic or modacrylic, and (4) a polyolefin fiber, such as polyethylene or polypropylene. Application to a polyester fiber or a polyamide fiber among the above is preferable. A synthetic fiber other than an acrylic fiber for production of carbon fiber is preferably used.

[0117] The proportion of adhering the treatment agent to the synthetic fiber is not limited in particular and preferably, the treatment agent is adhered such as to be of a proportion of not less than 0.1% by mass to not more than 3% by mass (not including water or other solvent) with respect to the synthetic fiber. By such arrangement, the effects of the present invention can be further improved. The method for adhering the treatment agent is not limited in particular and a known method, for example, a roller oiling method, a guide oiling method using a metering pump, an immersion oiling method, or a spray oiling method can be used.

[0118] Effects of the treatment agent and the synthetic fiber of the embodiments will now be described.The treatment agent of the embodiment contains the smoothing agent, the nonionic surfactant, the alcohol compound, and the specific phosphoric acid ester compound. Thereby, the heat resistance of the treatment agent is improved and the preservation stability of the treatment agent is also improved. And consequently, precipitates derived from the inorganic phosphoric acid and salts thereof that are formed by decomposition of the phosphoric acid ester P1 in particular, settling of the precipitates, and forming of tar during yarn production can be suppressed.

[0119] Also, fluctuation of tension due to abrasion of a running thread to which the treatment agent is applied and a roller, in other words, fluctuation of friction and forming of tar can be reduced.The above-described embodiments may be modified as follows. The abovedescribed embodiments and modifications described below can be implemented upon being combined with each other within a range that is not technically inconsistent.

[0120] • The treatment agent of the embodiments may further contain a stabilizer, an antistatic agent, a binder, an antioxidant, an ultraviolet absorber, and other ingredients that are ordinarily used in treatment agents for quality maintenance of the treatment agent within a range that does not impair the effects of the present invention.

[0121] • The treatment agent of the embodiments may further contain water within a range that does not impair the effects of the present invention. The content of the water preferably exceeds 0% by mass but is not more than 4% by mass from a standpoint of improving the stability of the treatment agent.EXAMPLES

[0122] Examples will now be given below to describe the features and effects of the present invention more specifically, but the present invention is not restricted to these examples. In the following description of examples and comparative examples, parts means parts by mass and % means % by mass.

[0123] Experimental Part 1 (Synthesis of phosphoric acid ester compounds (C1)) Phosphoric acid ester compounds used in the respective examples and comparativeexamples were synthesized by a method described below.

[0124] • Synthesis of phosphoric acid ester compound (P-1)Isocetyl alcohol dehydrated under reduced pressure at 105°C was used as a raw material alcohol. The isocetyl alcohol was charged into a four-necked flask, diphosphorus pentaoxide was gradually loaded thereinto under a nitrogen atmosphere, and stirring at 70 ± 5°C was performed for 3 hours to carry out a phosphorylation reaction. The phosphorylation product was purified by column chromatography, then mixed with dibutylethanolamine as a neutralizer, and stirred at 50°C for 1 hour to synthesize a phosphoric acid ester compound (P1). The charged amount of the dibutylethanolamine was determined by calculating from the amount and acid value (acid value at a titration point at approximately pH 11 determined by titration with a 1 mol / L KOH solution) of the phosphorylation product and a base value of dibutylethanolamine (charged amount of dibutylethanolamine = charged amount of phosphorylation product x acid value / base value).

[0125] • Phosphoric acid ester compounds (P-2 to P-6, rP-1, and rP-2)Phosphoric acid ester compounds (P-2 to P-6) were synthesized by the same method as P-1 using raw materials indicated in Table 1 as raw material alcohols. Phosphorylation reactions of phosphoric acid ester compounds (rP-1 and rP-2) were carried out underatmospheric pressure with the raw material diphosphorus pentaoxide being placed under atmosphere (room temperature: approximately 27°C; relative humidity: approximately 80%) until loading of an entire amount from after unsealing of a reagent bottle (approximately 30 minutes were required from start of loading to end of loading). The phosphoric acid ester compound (rP-1) was neutralized by charging the phosphorylation product into a potassium hydroxide aqueous solution and stirring and was then used in the treatment agent after being air-dried.

[0126] The raw material alcohols that are to constitute alkyl groups of the phosphoric acid ester compounds (P-1 to P-6, rP-1, and rP-2) to be blended in treatment agents and neutralizers (alkalis) for forming salts are respectively indicated in the "Raw material alcohol" column and the "Neutralizer" column of Table 1.

[0127] • P nucleus NMR measurement methodPretreatment was performed by adding 0.15 g of laurylamine as alkali to 0.10 g of each of the phosphoric acid ester compounds (C1) synthesized as described above and stirring. Respective P nucleus NMR integral values attributed to phosphoric acid esters P1 to P4 were then determined using 31P-NMR.

[0128] Values measured by 31P-NMR (trade name: MERCURY plus NMR Spectrometer System, 300 MHz manufactured by Valian Inc.) were used for P nucleus NMR integral ratios. Deuterated chloroform was used as a solvent. The respective P nucleus NMR integral ratios (%) attributed to the phosphoric acid esters P1 to P4 were determined based on Numerical Formulae (1) to (4) described above. The values calculated for the respective phosphoric acid ester compounds (C1) from Numerical Formulae (1) to (4) were equal to P nucleus NMR integral ratios of the treatment agents in which these respective phosphoric acid ester compounds (C1) were blended.

[0129] The respective P nucleus NMR integral ratios (%) of the phosphoric acid esters P1 to P4 determined by P nucleus NMR measurement of the phosphoric acid ester compounds are respectively indicated in the "P nucleus NMR integral ratio (%)" column of Table 1.

[0130] [Table 1]

[0131] Experimental Part 2 (Preparation of treatment agents)Treatment agents used in the respective examples and comparative examples were prepared using respective ingredients indicated in Tables 2 and 3 by a preparation method described below.

[0132] 30 parts (%) of trimethylolpropane trioleate (L-1), 30 parts (%) of rapeseed oil (L-3), 2 parts (%) of diisostearyl thiodipropionate (LS-1), and 1 part (%) of trimethylolpropane dioleate (pL-1) as smoothing agents (A), 5 parts (%) of a random adduct of 10 moles of EO and 10 moles of PO with 1 mole of isotridecanol (N-3), 14 parts (%) of an adduct of 10 moles of EO with 1 mole of hydrogenated castor oil (N-4), 14 parts (%) of a compound obtained by adding 20 moles of EO to 1 mole of hydrogenated castor oil and then esterifying with 3 moles of oleic acid (N-5), and 1 part (%) of an adduct of 3 moles of EO with 1 mole of laurylamine (N-12) as nonionic surfactants, 1.5 parts (%) of the phosphoric acid ester compound (P-1) and 1.2 parts (%) of sodium secondary alkanesulfonate (C = 14 to 17) (S-1) as ionic surfactants,and 0.04 parts (%) of isocetyl alcohol (AL-1), 0.01 parts (%) of polyethylene glycol (average molecular weight: 200) (D-1), and 0.25 parts (%) of ethylene glycol (D-5) as alcohol compounds (D) were mixed well and made uniform to prepare a treatment agent of Example 1.

[0133] For each of Examples 2 to 18 and Comparative Examples 1 to 4, a treatment agent was prepared in the same manner as in Example 1 by mixing the smoothing agents (A), the nonionic surfactants (B), the ionic surfactants (C), and the alcohol compounds (D) at proportions indicated in Tables 2 and 3. However, in each of Examples 3, 4, 5, 6, 7, and 9, besides the raw materials of Table 2, 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanuric acid was added as an antioxidant at a proportion of 0.8 parts with respect to 100 parts of treatment agent.

[0134] Phosphoric acid ions in each treatment agent were measured by an ion chromatography method of conditions indicated below. Results are indicated in the "Phosphoric acid ion concentration" columns of Tables 2 and 3.1 g of sample (including volatile content) was measured out accurately, a 10% 2-propanol aqueous solution was added thereto little by little while stirring, and a solution made up to a fixed volume with a 100 mL volumetric flask was prepared. 1 mL of the prepared aqueous solution was passed through an ODS (with an octadecyl group chemically bonded to silica gel) pretreatment cartridge and used in ion chromatography analysis. Detection was performed with the following ion chromatography conditions. A detection amount was measured as a peak area ratio with respect to a standard solution of known concentration and converted to amount of phosphoric acid ions (PO43").

[0135] <Ion chromatography conditions>Device: IC2001, manufactured by Tosoh Corporation; using suppressorAnalytical column: TSKgel SuperIC-AZ, manufactured by Tosoh Corporation; 4.6 mm inner diameter x 75 mm lengthGuard column: TSKgel guard column SuperIC-AZ, manufactured by Tosoh Corporation; 4.0 mm inner diameter x 10 mm lengthEluent: 23% by volume methanol aqueous solution of 4.8 mmol of Na2CO3 and 2.8 mmol of NaHCO3Flow rate: 0.6 mL / min.

[0136] The types and contents of the smoothing agents (A), the nonionic surfactants (B), the ionic surfactants (C), and the alcohol compounds (D) in the treatment agents of the respective examples are respectively indicated in the "Smoothing agent (A)" columns, the "Nonionic surfactant (B)" columns, the "Ionic surfactant (C)" columns, and the "Alcohol compound (D)" columns of Tables 2 and 3.

[0137] The mass ratio of a complete ester compound (A1) and a sulfur-containing ester compound (A2) and the mass ratio of the complete ester compound (A1) and a partial ester compound (A3) in each of the treatment agents of the respective examples are respectively indicated in the "Content ratio (A1) / (A2)" columns and the "Content ratio (A1) / (A3)" columns of Tables 2 and 3.

[0138] [Table 2]

[0139] [Table 3]

[0140] Details of the smoothing agents (A), the nonionic surfactants (B), the ionicsurfactants (C), and the alcohol compounds (D) indicated in Tables 2 and 3 are as follows. (Smoothing agent (A))L-1: trimethylolpropane trioleate L-2: diisostearyl adipate L-3: rapeseed oilLS-1: diisostearyl thiodipropionate LS-2: dioleyl thiodipropionate pL-1: trimethylolpropane dioleate pL-2: glycerin dioleate eL-1: octyl palmitate (Nonionic surfactant (B))N-1: adduct of 10 moles of EO with 1 mole of oleyl alcohol N-2: adduct of 10 moles of EO with 1 mole of isotridecanol N-3: random adduct of 10 moles of EO and 10 moles of PO with 1 mole of isotridecanolN-4: adduct of 10 moles of EO with 1 mole of hydrogenated castor oil N-5: compound obtained by adding 20 moles of EO to 1 mole of hydrogenated castor oil and then esterifying with 3 moles of oleic acidN-6: compound (average molecular weight: 5000) obtained by adding 25 moles of EO to 1 mole of hydrogenated castor oil and then crosslinking with adipic acid and terminal esterifying with stearic acidN-7: sorbitan monooleate N-8: sorbitan trioleateN-9: diester of polyethylene glycol (average molecular weight: 600) and oleic acid N-10: diester of polyethylene glycol (average molecular weight: 400) and lauricacidN-11: monoester of polyethylene glycol (average molecular weight: 600) and oleicacidN-12: adduct of 3 moles of EO with 1 mole of laurylamine N-13: adduct of 10 moles of EO with 1 mole of laurylamine (Ionic surfactant (C))S-1: sodium secondary alkanesulfonate (C = 14 to 17)S-2: sodium dioctyl sulfosuccinateS-3: potassium dodecyl benzenesulfonateS-4: sodium α-olefin sulfonate(Alcohol compound (D))AL-1: isocetyl alcoholAL-2: isostearyl alcoholAL-3: oleyl alcoholAL-4: isotetracosanolD-1: polyethylene glycol (average molecular weight: 200)D-2: polyethylene glycol (average molecular weight: 400)D-3: polypropylene glycol (average molecular weight: 400)D-4: polyoxyethylene propylene glycol (PO 1 mole, EO 4 moles)D-5: Ethylene glycolD-6: Propylene glycol D-7: Diethylene glycolExperimental Part 3 (Evaluation of treatment agents and synthetic fibers)• Evaluation of stabilityThe treatment agent of Example 1 and treatment agents with which the phosphoric acid ester compound (P-1) in the treatment agent of Example 1 is changed to another phosphoric acid ester compound (P-2 to 6, rP-1, or rP-2) indicated in Table 1 were prepared. The blending amount of the phosphoric acid compound was adjusted such that the substance amount of phosphorus contained in the treatment agent would be the same as in the case of blending the phosphoric acid compound (P-1). With each of these, 100 g were placed in a vial. Next, 1 g of distilled water was added thereto. Each vial was left to stand for 3 days at 70°C, whether or not particulate matter derived from inorganic phosphoric acid precipitated anew on a bottom portion of the vial was observed, and stability was judged based on criteria indicated below. The results are indicated in the "Stability" column of Table 1.

[0141] o (fair): Precipitation did not occur. x (poor): Precipitation occurred.• Evaluation of tension fluctuationEach treatment agent was diluted uniformly with a diluent of ion exchanged water or organic solvent as necessary and made into a 15% solution. Polyethylene terephthalate fibers (unoiled yarn) of 1000 decitex, 192 filaments, and intrinsic viscosity of 0.93 were made into a test yarn by applying the solution by an oiling roller oiling method such as to be of an application amount of 3.0% by mass as nonvolatile content and then drying the diluent.

[0142] The test yarn was made to run at an initial tension of 1.5 kg and a yarn speed of 1.0 m / minute while in contact with a textured chromium pin with a surface temperature of 250°C and a tension value of the yarn after contact with the textured chromium pin was measured. A running time at a point at which the tension value increased by 10% from that of 20 minutes after running was recorded and evaluated based on criteria indicated below. The results are indicated in the "Tension fluctuation" columns of Tables 2 and 3.

[0143] oo (satisfactory): Not less than 6 hours.o (fair): Not less than 3 hours but less than 6 hours. x (poor): Less than 3 hours.• Evaluation of tarAs heat resistance evaluation of each treatment agent, tar accumulated on the textured chromium pin after elapse of 6 hours in the tension fluctuation test was observed and evaluated based on criteria indicated below. The results are indicated in the "Tar" columns of Tables 2 and 3.

[0144] oo (satisfactory): Not much tar was observed. o (fair): Tar of light brown color was observed.x (poor): Tar of dark brown color or black color was observed.As is clear from the evaluation results of Tables 1 to 3, it was confirmed that by the treatment agent of the present invention, excellent preservation stability is provided and tension fluctuation and tar are reduced.

[0145] The present invention also encompasses the following embodiments.(Additional Embodiment 1)A synthetic fiber treatment agent (excluding, however, acrylic fiber treatment agent for production of carbon fiber) comprising a smoothing agent (A), a nonionic surfactant (B), an ionic surfactant (C) that includes a phosphoric acid ester compound (C1), and an alcohol compound (D), whereinthe phosphoric acid ester compound (C1) includes a phosphoric acid ester P4 represented by Chemical Formula (4) shown below and optionally further includes at least one selected from among a phosphoric acid ester P1 represented by Chemical Formula (1) shown below, a phosphoric acid ester P2 represented by Chemical Formula (2) shown below, and a phosphoric acid ester P3 represented by Chemical Formula (3) shown below, and assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 7%,

[0146]

[0147] in Chemical Formula (1),R1 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms,M1 and M2 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and m is an integer of 2 or 3, and

[0148]

[0149] in Chemical Formula (2),R2 and R3 are each an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms,M3 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and n is an integer of 2 or 3, and

[0150]

[0151] in Chemical Formula (3),R4 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, andM4 and M5 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and

[0152]

[0153] in Chemical Formula (4),R5 and R6 are each an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, andM6 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium.

[0154] (Additional Embodiment 2)The synthetic fiber treatment agent according to additional embodiment 1, wherein the phosphoric acid ester compound (C1) further includes the phosphoric acid ester P2 and assuming that the sum of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is not less than 5% and not more than 50%.

[0155] (Additional Embodiment 3)The synthetic fiber treatment agent according to additional embodiment 1 or 2, wherein the phosphoric acid ester compound (C1) further includes the phosphoric acid ester P2 and assuming that the sum of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 5%, and the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is not less than 10% and not more than 45%.

[0156] (Additional Embodiment 4)The synthetic fiber treatment agent according to any one of additional embodiments 1 to 3, wherein the alcohol compound (D) includes at least one selected from among monohydric alcohols and diols.

[0157] (Additional Embodiment 5)The synthetic fiber treatment agent according to additional embodiment 4, wherein the alcohol compound (D) includes a monohydric alcohol and the content of the monohydricalcohol in the synthetic fiber treatment agent is not less than 0.0001% by mass and not morethan 3% by mass.

[0158] (Additional Embodiment 6)The synthetic fiber treatment agent according to additional embodiment 4 or 5, wherein the alcohol compound (D) includes a diol and the content of the diol in the synthetic fiber treatment agent is not less than 0.001% by mass and not more than 5% by mass.

[0159] (Additional Embodiment 7)The synthetic fiber treatment agent according to any one of additional embodiments 1 to 6, whereinthe smoothing agent (A) includes at least one selected from among a complete ester compound (A1), a sulfur-containing ester compound (A2), and a partial ester compound (A3), the complete ester compound (A1) is at least one selected from among complete ester compounds of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms and complete ester compounds of a monohydric alcohol with not less than 8 and not more than 24 carbon atoms and a polyvalent fatty acid with not less than 3 and not more than 10 carbon atoms, andthe partial ester compound (A3) is a partial ester compound of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms.

[0160] (Additional Embodiment 8)The synthetic fiber treatment agent according to additional embodiment 7, wherein the smoothing agent (A) includes the complete ester compound (A1) and the content of the complete ester compound (A1) in the synthetic fiber treatment agent is not less than 30% by mass and not more than 70% by mass.

[0161] (Additional Embodiment 9)The synthetic fiber treatment agent according to additional embodiment 8, wherein the smoothing agent (A) includes the sulfur-containing ester compound (A2).

[0162] (Additional Embodiment 10)The synthetic fiber treatment agent according to additional embodiment 9, wherein the mass ratio of the contents of the complete ester compound (A1) and the sulfur-containing ester compound (A2) is such that complete ester compound (A1) / sulfur-containing ester compound (A2) is not less than 1 / 1 and not more than 100 / 1.

[0163] (Additional Embodiment 11)The synthetic fiber treatment agent according to any one of additional embodiments 8 to 10, wherein the smoothing agent (A) includes the partial ester compound (A3).

[0164] (Additional Embodiment 12)The synthetic fiber treatment agent according to additional embodiment 11, wherein the mass ratio of the contents of the complete ester compound (A1) and the partial ester compound (A3) is such that complete ester compound (A1) / partial ester compound (A3) is not less than 1 / 1 and not more than 10000 / 1.

[0165] (Additional Embodiment 13)The synthetic fiber treatment agent according to any one of additional embodiments 1 to 12, wherein the synthetic fiber treatment agent has a phosphoric acid ion concentration of not more than 200 ppm as measured by an ion chromatography method.

[0166] (Additional Embodiment 14)A synthetic fiber (excluding, however, acrylic fiber for production of carbon fiber) to which the synthetic fiber treatment agent according to any one of additional embodiments 1to 13 is adhered.

Claims

1. A synthetic fiber treatment agent comprising a smoothing agent (A), a nonionic surfactant (B), an ionic surfactant (C) that includes a phosphoric acid ester compound (C1), and an alcohol compound (D), wherein the phosphoric acid ester compound (C1) includes at least one selected from among a phosphoric acid ester P1 represented by Chemical Formula (1) shown below, a phosphoric acid ester P2 represented by Chemical Formula (2) shown below, a phosphoric acid ester P3 represented by Chemical Formula (3) shown below, and a phosphoric acid ester P4 represented by Chemical Formula (4) shown below, and assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 7%, in Chemical Formula (1), R1 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, M1 and M2 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and m is an integer of 2 or 3, and in Chemical Formula (2), R2 and R3 are each an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, M3 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and n is an integer of 2 or 3, and in Chemical Formula (3), R4 is an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, and M4 and M5 are each a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium, and in Chemical Formula (4), R5 and R6 are each an alkyl group with not less than 8 and not more than 24 carbon atoms, an alkenyl group with not less than 8 and not more than 24 carbon atoms, or a residue obtained by removing a hydroxy group from an adduct of not less than 1 mole and not more than 20 moles of an alkylene oxide with not less than 2 and not more than 3 carbon atoms with 1 mole of an aliphatic alcohol with not less than 8 and not more than 24 carbon atoms, and M6 is a hydrogen atom, an alkali metal, an alkali earth metal (1 / 2), an organic amine salt, ammonium, or a phosphonium.

2. The synthetic fiber treatment agent according to claim 1, wherein the phosphoric acid ester compound (C1) includes the phosphoric acid ester P2 and assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is not less than 5% and not more than 50%.

3. The synthetic fiber treatment agent according to claim 1 or 2, wherein the phosphoric acid ester compound (C1) includes the phosphoric acid ester P2 and assuming that the total of P nucleus NMR integral ratios attributed to the phosphoric acid ester P1, the phosphoric acid ester P2, the phosphoric acid ester P3, and the phosphoric acid ester P4 is 100%, the P nucleus NMR integral ratio attributed to the phosphoric acid ester P1 is not more than 5%, and the P nucleus NMR integral ratio attributed to the phosphoric acid ester P2 is not less than 10% and not more than 45%.

4. The synthetic fiber treatment agent according to any one of claims 1 to 3, wherein the alcohol compound (D) includes at least one selected from among monohydric alcohols and diols.

5. The synthetic fiber treatment agent according to claim 4, wherein the alcohol compound (D) includes a monohydric alcohol and the content of the monohydric alcohol in the synthetic fiber treatment agent is not less than 0.0001% by mass and not more than 3% by mass.

6. The synthetic fiber treatment agent according to claim 4 or 5, wherein the alcohol compound (D) includes a diol and the content of the diol in the synthetic fiber treatment agent is not less than 0.001% by mass and not more than 5% by mass.

7. The synthetic fiber treatment agent according to any one of claims 1 to 6, wherein the smoothing agent (A) includes at least one selected from among a complete ester compound (A1), a sulfur-containing ester compound (A2), and a partial ester compound (A3), the complete ester compound (A1) is at least one selected from among complete ester compounds of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms and complete ester compounds of a monohydric alcohol with not less than 8 and not more than 24 carbon atoms and a polyvalent fatty acid with not less than 3 and not more than 10 carbon atoms, and the partial ester compound (A3) is a partial ester compound of a polyhydric alcohol having a chain structure with not less than 3 and not more than 6 carbon atoms and a monovalent fatty acid with not less than 8 and not more than 24 carbon atoms.

8. The synthetic fiber treatment agent according to claim 7, wherein the smoothing agent (A) includes the complete ester compound (A1) and the content of the complete ester compound (A1) in the synthetic fiber treatment agent is not less than 30% by mass and not more than 70% by mass.

9. The synthetic fiber treatment agent according to claim 8, wherein the smoothing agent (A) includes the sulfur-containing ester compound (A2).

10. The synthetic fiber treatment agent according to claim 9, wherein the mass ratio of the contents of the complete ester compound (A1) and the sulfur-containing ester compound (A2) is such that complete ester compound (A1) / sulfur-containing ester compound (A2) is not less than 1 / 1 and not more than 100 / 1.

11. The synthetic fiber treatment agent according to any one of claims 8 to 10, wherein the smoothing agent (A) includes the partial ester compound (A3).

12. The synthetic fiber treatment agent according to claim 11, wherein the mass ratio of the contents of the complete ester compound (A1) and the partial ester compound (A3) is such that complete ester compound (A1) / partial ester compound (A3) is not less than 1 / 1 and not more than 10000 / 1.

13. The synthetic fiber treatment agent according to any one of claims 1 to 12, wherein the synthetic fiber treatment agent has a phosphoric acid ion concentration of not more than 200 ppm as measured by an ion chromatography method.

14. A synthetic fiber to which the synthetic fiber treatment agent according to any one of claims 1 to 13 is adhered.